Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
NERV
NGEN
Add up to 3 more stocks
NERV
Minerva Neurosciences, Inc.
+3.61%
$3.44+0.12Delayed quote: Oct 6, 2026, 2:34 PM EDT
Market Cap
$160.27M
52W Range
$2.12 - $12.46
NGEN
NervGen Pharma Corp. Common stock
-0.47%
$1.80-0.01Delayed quote: Oct 6, 2026, 2:30 PM EDT
Market Cap
$148.07M
52W Range
$1.58 - $6.30
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | N/A | 12.15 |
| P/S Ratio | N/A | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% |
| ROE | N/A | -397.4% |
| ROA | -414.7% | -76.1% |
| ROIC | -38.6% | -223.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 20.14 | 1.23 |
| Quick Ratio | 20.14 | 1.23 |
| Debt/Equity | N/A | 0.00 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.